This useful study employs optogenetics, genetically-encoded dopamine and serotonin sensors, and patch-clamp electrophysiology to investigate modulations of neurotransmitter release between striatal ...

A third girl below the age of 15 has been arrested in connection to the shooting of two girls in the Russell neighborhood in May.

The Phase 3 study will evaluate the efficacy and safety of the investigational drug felzartamab compared to tacrolimus in adults diagnosed with primary membranous nephropathy (PMN).

Phase 3 marks the final major round in the TS DOST 2025 admission cycle. Students who participated in registration and choice filling can now log in and view their seat allotment details.

TS DOST 2025: The Telangana State Council of Higher Education (TSCHE) has officially released the TS DOST 2025 phase 3 seat allotment list for undergraduate (UG) admissions.

PANOVA-3 is an international, prospective, randomized, open-label, controlled Phase 3 clinical trial designed to test the efficacy and safety of Tumor Treating Fields (TTFields) therapy used ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents with uncontrolled asthma in two phase 3 trials, according to a press ...

Addressing this knowledge gap is essential to clarify whether CF input is uniformly critical or phase-specific in motor learning and memory. To address this gap, we investigated the necessity of ...

Johnson & Johnson is ending the phase 3 VENTURA clinical development program evaluating aticaprant, a selective kappa receptor antagonist, as an adjunctive treatment for major depressive disorder ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the stage for the Chicago-based firm to submit the drug candidate for ...

As recently as last month, the biotech had been setting out plans for a phase 3 trial of the combo treatment for later in 2025 on the back of phase 1 data showing that Lunre+Camo achieved a 25.9% ...